Abstracts & Presentations
International Conferences
2017 International Conferences
(By conference, by month, by author)
IAS HIV Cure & Cancer Forum, Paris, France, July 2017
Lee WS et al, HIV-1-specific ADCC following anti-latency therapy and
analytical treatment interruption -
Abstract |
Poster
9th IAS Conference on HIV Science (IAS 2017), Paris, France, July
2017
Castillo-Mancilla JR (Gardner EM, presenting) et al - Association of
sub-optimal antiretroviral therapy (ART) adherence with inflammation in
virologically-suppressed, HIV-infected individuals: a sub-analysis of the
Strategies for Management of Antiretroviral Therapy (SMART) study -
Abstract |
Poster
Lee WS et al - HIV-1-specific ADCC following anti-latency therapy and
analytical treatment interruption -
Abstract |
Poster
Rappoport C (Corbelli GM, presenting) et al - Participant reasons for not
initiating antiretroviral treatment despite compelling evidence following
early unblinding of the Strategic Timing of Antiretroviral Treatment (START)
trial -
Abstract |
Poster
Zanotto AD et al - Associations between baseline inflammatory markers,
lung function, and immediate vs. deferred ART in the START Pulmonary
Substudy -
Abstract |
Poster
CROI 2017 (Conference on Retroviruses and Opportunistic Infections),
Seattle, Washington, February 2017
Baker J et al, Association of inflammation and coagulation with clinical
risk in the START trial -
Abstract |
Poster
Baker J et al, The effect of ART on inflammation, coagulation and vascular
injury in START -
Abstract |
Poster
Borges ÁH et al, Benefit of continuous/immediate ART on disease risk: SMART
& START combined analysis -
Abstract |
Poster
Schlusser KE et al, Comparison of self-report to biomarkers of recent
infection -
Abstract |
Poster
Schlusser KE et al, Early treatment is likely more important than previously
thought -
Abstract |
Poster
Sereti I et al, ART in HIV persons with pre-treatment viremia ≤ 3000 c/mL:
the START study -
Abstract |
Poster
